Hospital News and Research

RSS

JAK3 pathway highlighted as leukemia target

An intriguing study published in Expert Review of Anticancer Therapy has revealed that the signaling protein JAK3 represents a viable target in the treatment of a broad range of B-lineage cancers, including acute lymphoblastic leukemia (ALL).

28 Nov 2010

Segasist Technologies receives HTX funding for clinical validation of prostate MRI software

Segasist Technologies, a Canadian software company developing contouring productivity tools for medical imaging, has today announced the receipt of funding from The Health Technology Exchange (HTX) towards support of clinical validation of its software, to be conducted at the Lawson Health Research Institute and London Health Sciences Centre (London, Ontario). Experts from Sunnybrook Research Institute and Sunnybrook Health Sciences Centre will also participate in the validation process by providing input in the form of gold standard contours.

26 Nov 2010

CQDM and Alsace BioValley enter long term research collaboration

Alsace BioValley, a French competitive health cluster dedicated to therapeutic innovation and CQDM (Québec Consortium for Drug Discovery) sign in Paris today an agreement on a bilateral partnership for the benefit of Alsatian and Quebec research centers and industries in the life sciences and health sector.

26 Nov 2010

Good Samaritan Hospital of Los Angeles wins Paradigm Award for labor excellence

The Paradigm Award Committee announced that Good Samaritan Hospital of Los Angeles, a leading hospital based in Southern California, was recently selected to receive the prestigious Paradigm Award.

26 Nov 2010

Researchers synthesize iron compounds that inhibit growth of Mycobacterium tuberculosis

A team of researchers from Spain and Latin America have synthesized two iron compounds that inhibit the in vitro growth of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Due their low level of toxicity in mammel cells, the compounds could be used in the future as therapeutic agents and hospital disinfectants.

26 Nov 2010

Circle social enterprise to run Hinchingbrooke Healthcare NHS Trust in Huntingdonshire

Circle, the employee-owned social enterprise, has today been chosen as the preferred partner to run Hinchingbrooke Healthcare NHS Trust in Huntingdonshire.

26 Nov 2010

Canadian Red Cross announces First Responder Initiative for disaster response

The Canadian Red Cross is pleased to announce the First Responder Initiative, which increases the Red Cross' capacity to prepare for and rapidly respond to disasters and includes the ability to quickly deploy tented field hospitals.

26 Nov 2010

New findings provide insight into brain development

St. Jude Children's Research Hospital investigators have identified key components of a signaling pathway that controls the departure of neurons from the brain niche where they form and allows these cells to start migrating to their final destination. Defects in this system affect the architecture of the brain and are associated with epilepsy, mental retardation and perhaps malignant brain tumors.

25 Nov 2010

Hospital errors in U.S. continue despite efforts: Study

A new study published Thursday in the New England Journal of Medicine (NEJM) showed that all the efforts to make American hospitals error free and safe are inadequate.

25 Nov 2010

Pollen burst leads to 10 year spike in asthma cases

Melbourne hospitals are flooded with patients with respiratory problems in a phenomenon experts have described as “thunderstorm asthma”.

25 Nov 2010

NSW emergency departments falling short on targets

According to the Bureau of Health Information’s latest Hospital Quarterly Figures emergency departments in New South Wales hospitals are still not meeting recommended waiting targets. The figures reveal that more than a third of patients transferred by an ambulance waited longer than the accepted 30 minutes to be taken into the care of emergency departments.

25 Nov 2010

Looking back and moving forward: 100 years of Pneumococcal vaccination

"Since the introduction of smallpox vaccination by Sir Edward Jenner in 1796, it took 184 years until the WHO could declare the world free of smallpox. How long will it take to eliminate pneumococcus from the world?"

25 Nov 2010

Unique collaboration results in new bandage splint for hip surgery patients

The new splint can reduce the need for large external support structures to fixate the hip following hip surgery. The secret behind the fast development is collaboration between a research scientist, an enterprise and a full-time student using this case for her bachelor project.

25 Nov 2010

New study finds no decrease in patient harm at hospitals

Despite concerted efforts, no decreases in patient harm were detected at 10 randomly selected North Carolina hospitals between 2002 and 2007, according to a new study from the Stanford University School of Medicine, Harvard Medical School and the Institute for Healthcare Improvement.

25 Nov 2010

UMDNJ researchers develop comprehensive strategy for recovery from smoking addiction

Researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ), following 10 years of studying tobacco use among smokers with mental illness, have developed a comprehensive strategy for recovery from smoking addiction that could serve as a nationwide model.

25 Nov 2010

Specialists suggest U.S. should stockpile cholera vaccines for rapid deployment at disease outbreak

As the cholera epidemic in Haiti continues to rage, public health workers are focusing their efforts on treating the tens of thousands who have already been hospitalized with cholera-like symptoms and providing clean water and adequate sanitation to control the disease's spread.

25 Nov 2010

Weather associated with trauma admissions

Every 5-C rise in maximum temperature pushes up the rate of hospital admissions for serious injuries among children, reveals one of the largest studies of its kind published online in Emergency Medicine Journal.

25 Nov 2010

Research finds ways to tackle drug resistance in melanoma

The past year has brought to light both the promise and the frustration of developing new drugs to treat melanoma, the most deadly form of skin cancer. Early clinical tests of a candidate drug aimed at a crucial cancer-causing gene revealed impressive results in patients whose cancers resisted all currently available treatments.

25 Nov 2010

Breastfeeding while remaining on epilepsy medications may not affect child's IQ

There's good news for women with epilepsy. Breastfeeding your baby while taking your seizure medication may have no harmful effect on your child's IQ later on, according to a study published in the November 24, 2010, online issue of Neurology-, the medical journal of the American Academy of Neurology.

25 Nov 2010

American Board Diplomat joins Ascendant Neuro for treating pain management

Ascendant Neuro is pleased to announce the addition of Jack A. Chapman, M.D., a nationally recognized pain management specialist, who will work to further advance the group's minimally invasive pain treatment techniques through the innovative use of neurostimulators and other conservative treatments.

25 Nov 2010